The doctor explains the experimental drug that acts on GLP-1, GIP and glucagon receptors and why it's getting attention.
Recap by typeshit. Post by @lisaoldsonmd on Instagram.
A brief Facebook post says a daily pill might help people who worry about putting weight back on once they come off Wegovy. It names no drug or study.
In 367 adults with type 2 diabetes, the top combo dose beat 14.8% on tirzepatide alone at 48 weeks. Lilly plans phase 3 by late 2026.
Alessandro Sette's lab will track T cell responses in people before and after starting GLP-1s, including to Parkinson's-linked proteins. He is enrolling himself too.
12:35
Dr. Eric Berg walks through the basics of peptides in a broad explainer. Treat any health claims as his own views.
Reports say the Trump administration may let some compounding pharmacies dispense peptides not fully safety tested, and an Auckland academic is concerned.
The two doctors attended the EASD diabetes conference in Milan and talk through what surprised them after day one of new GLP-1, obesity and diabetes research.
Loading…